Dr. DiFrancesco ( is deeply enthusiastic about new developments in the treatment of addiction and has launched a new website ...

Nexalin has received patent approval from the USPTO for its DIFS method for treating substance use disorders (SUD).

Scientists develop lab-grown model of the human sensory pathway to investigate how pain signals are transmitted to the brain.

Chocolate contains caffeine, theobromine, and phenylethylamine, all of which have psychoactive effects. These substances may ...

Patent Approval Reinforces Nexalin’s Leadership in Non-Invasive Brain Stimulation for Addiction TreatmentHOUSTON, TX, April ...